While CM4620 is not currently utilized for cancer treatment, its remarkable ability to selectively inhibit STIM1/Orai1-mediated SOCE makes it highly promising for therapeutic applications in tumors with upregulated STIM1/Orai1 expression. The gene discussed is ORAI1; the disease is cancer.